Format

Send to

Choose Destination
Br J Hosp Med. 1996 Apr 17-30;55(8):517-20.

Neuroleptic malignant syndrome.

Author information

1
Cheam Resource Centre, St Helier Trust University Hospital, Surrey.

Abstract

Neuroleptic malignant syndrome is a rare, idiosyncratic condition related to neuroleptic use which may develop at any stage during neuroleptic treatment and can prove fatal. Although most commonly seen in psychiatric patients, anyone prescribed a neuroleptic is at risk and it has been associated with other agents. This article discusses its recognition, risk factors, clinical course and treatment, together with a summary of current thinking on its aetiology.

PMID:
8732227
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center